Home
Conditions
Carcinoma, Hepatocellular

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,143 public trials 560 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Recruiting

Organoid Models of Hepatocellular Carcinoma

NCT06929845

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC CEMAD, Largo A. Gemelli, 8 Roma, Italy

View Trial Details

Recruiting

Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC

NCT07639138

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Peking Union Medical College Hospital Beijing, No. 1 Shuaifuyuan, Dongcheng District, Beijing, China, China

View Trial Details

Recruiting

Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma

NCT07793695

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Hefei, Anhui, China

View Trial Details

Recruiting

Irreversible Electroporation Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma

NCT07832006

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Peking Union Medical College Hospital Beijing, No. 1 Shuaifuyuan, Dongcheng District, Beijing, China, China

View Trial Details

Recruiting

Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence

NCT06954116

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

NCT07627191

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +22 more
Locations: University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Recruiting

Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.

NCT07027436

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Juravinski Hospital Hamilton, Ontario, Canada

London Health Sciences Centre London, Ontario, Canada

View Trial Details

Recruiting

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

NCT02851784

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

NCT07824583

Conditions: Abdominal Cancer, Adenocarcinoma, Carcinoma, +25 more
Locations: Siteman Cancer Center Washington University St Louis, Missouri, United States

University Hospital Cleveland Medical Center Cleveland, Ohio, United States

View Trial Details

Recruiting

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

NCT06007846

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Inova Schar Cancer Institute Fairfax, Virginia, United States

Inova Health Care Service Falls Church, Virginia, United States

View Trial Details

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular trial results

Related conditions